The reason may be that the tyrosine kinase domain of the L858R mutant has a weaker binding force to EGFR-TKIs than that of the exon 19 deletion [28] and co-mutation is more frequent in the L858R-mutant NSCLC [29–31]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.